A drug maker recently doubled the price of chloroquine — but in response to the coronavirus pandemic, it’s cutting it in half
WASHINGTON — A company that makes a medication increasingly touted as a promising coronavirus treatment, known as chloroquine, doubled the drug’s price in late 2019 — but says it has now cut the price in half, to its original level, in response to the pandemic.
Rising Pharmaceuticals, a New Jersey-based drug company, hiked the price of its chloroquine phosphate tablets 98% between December 2019 and January 2020, according to data provided to STAT by the publishing and analytics company Elsevier, from roughly $3.87 to $7.66 for a 250-milligram tablet.
